NTLA Today - Jul 09: Stock Takes a Small Dip
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
So, what happened? Well, NTLA opened the day strong but then kind of faded away. It got smoked for a little while, and by the end, it was sitting at $16.66. Not the best look, right? Trading volume was way below average, too, which usually means people aren’t super excited about it right now.
Now, why did this happen? There’s some chatter out there about how NTLA looks a bit pricey based on its sales but isn’t pulling in the returns investors want. Some folks are saying it could be overvalued by around 37% considering all the hype about gene editing. Yeah, that one stung a bit for some investors. Even with some positive vibes from late-stage trial data, it seems like the market's not fully buying into the hype just yet.
On the horizon, there’s talk about NTLA's gene-editing therapy. It’s still in the spotlight, and some retail investors are saying now's the time to jump in before it’s too late. So, there’s definitely some action brewing, but it’s a mixed bag.
That’s the scoop for today! Remember, I’m just here to share the info, not to give you financial advice. Keep it real, and catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません